Literature DB >> 20225862

Synthesis, antitubulin, and antiproliferative SAR of analogues of 2-methoxyestradiol-3,17-O,O-bis-sulfamate.

Fabrice Jourdan1, Mathew P Leese, Wolfgang Dohle, Ernest Hamel, Eric Ferrandis, Simon P Newman, Atul Purohit, Michael J Reed, Barry V L Potter.   

Abstract

The synthesis and antiproliferative activity of analogues of estradiol 3,17-O,O-bis-sulfamates (E2bisMATEs) are discussed. Modifications of the C-17 substituent reveal that an H-bond acceptor is essential for high antiproliferative activity. The local environment in which this H-bond acceptor lies can be varied to an extent. The C-17-oxygen linker can be deleted or substituted with an electronically neutral methylene group, and replacement of the terminal NH(2) with a methyl group is also acceptable. Mesylates 10 and 14 prove equipotent to the E2bisMATEs 2 and 3, while sulfones 20 and 35 display enhanced in vitro antiproliferative activity. In addition, the SAR of 2-substituted estradiol-3-O-sulfamate derivatives as inhibitors of tubulin polymerization has been established for the first time. These agents inhibit the binding of radiolabeled colchicine to tubulin.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20225862     DOI: 10.1021/jm9018806

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  13 in total

1.  Analogue-based approaches in anti-cancer compound modelling: the relevance of QSAR models.

Authors:  Mohammed Hussaini Bohari; Hemant Kumar Srivastava; Garikapati Narahari Sastry
Journal:  Org Med Chem Lett       Date:  2011-07-18

2.  Tetrahydroisoquinolinone-based steroidomimetic and chimeric microtubule disruptors.

Authors:  Mathew P Leese; Fabrice L Jourdan; Meriel R Major; Wolfgang Dohle; Ernest Hamel; Eric Ferrandis; Ann Fiore; Philip G Kasprzyk; Barry V L Potter
Journal:  ChemMedChem       Date:  2013-10-09       Impact factor: 3.466

Review 3.  An overview of tubulin inhibitors that interact with the colchicine binding site.

Authors:  Yan Lu; Jianjun Chen; Min Xiao; Wei Li; Duane D Miller
Journal:  Pharm Res       Date:  2012-07-20       Impact factor: 4.200

4.  Analysis of tubulin alpha-1A/1B C-terminal tail post-translational poly-glutamylation reveals novel modification sites.

Authors:  Ziad J Sahab; Alexander Kirilyuk; Lihua Zhang; Zahraa I Khamis; Petr Pompach; Youme Sung; Stephen W Byers
Journal:  J Proteome Res       Date:  2012-02-15       Impact factor: 4.466

5.  Discovery of 7-hydroxy-6-methoxy-2-methyl-3-(3,4,5-trimethoxybenzoyl)benzo[b]furan (BNC105), a tubulin polymerization inhibitor with potent antiproliferative and tumor vascular disrupting properties.

Authors:  Bernard L Flynn; Gurmit S Gill; Damian W Grobelny; Jason H Chaplin; Dharam Paul; Annabell F Leske; Tina C Lavranos; David K Chalmers; Susan A Charman; Edmund Kostewicz; David M Shackleford; Julia Morizzi; Ernest Hamel; M Katherine Jung; Gabriel Kremmidiotis
Journal:  J Med Chem       Date:  2011-08-05       Impact factor: 7.446

6.  Optimisation of tetrahydroisoquinoline-based chimeric microtubule disruptors.

Authors:  Wolfgang Dohle; Mathew P Leese; Fabrice L Jourdan; Christopher J Chapman; Ernest Hamel; Eric Ferrandis; Barry V L Potter
Journal:  ChemMedChem       Date:  2014-05-12       Impact factor: 3.466

7.  Steroidomimetic Tetrahydroisoquinolines for the Design of New Microtubule Disruptors.

Authors:  Mathew P Leese; Fabrice Jourdan; Wolfgang Dohle; Meriel R Kimberley; Mark P Thomas; Ruoli Bai; Ernest Hamel; Eric Ferrandis; Barry V L Potter
Journal:  ACS Med Chem Lett       Date:  2011-10-31       Impact factor: 4.345

8.  A 2-methoxyestradiol bis-sulphamoylated derivative induces apoptosis in breast cell lines.

Authors:  Michelle Helen Visagie; Lyn-Marie Birkholtz; Anna Margaretha Joubert
Journal:  Cell Biosci       Date:  2015-04-22       Impact factor: 7.133

9.  2-Methoxyestradiol-bis-sulphamate refrains from inducing apoptosis and autophagy in a non-tumorigenic breast cell line.

Authors:  Michelle H Visagie; Anna M Joubert
Journal:  Cancer Cell Int       Date:  2012-08-20       Impact factor: 5.722

10.  In vitro evaluation of ESE-15-ol, an estradiol analogue with nanomolar antimitotic and carbonic anhydrase inhibitory activity.

Authors:  Barend Andre Stander; Fourie Joubert; Chingkuang Tu; Katherine H Sippel; Robert McKenna; Annie Margaretha Joubert
Journal:  PLoS One       Date:  2012-12-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.